Smithfield Trust’s Medifast MED Stock Holding History

Smithfield Trust’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-160	Closed	-$4K	–	756
2013 Q2	$4K	Buy	+160	New	+$4.2K	﹤0.01%	699

Other funds holding MED

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

GOFM

GGC Opportunity Fund Management San Francisco, California $526M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Smithfield Trust's MED Position: Q3 2013 in Review

Smithfield Trust sold out of Medifast (MED) in Q3 2013, closing a stake of 160 shares — an estimated $4K sold.

Smithfield Trust first reported a position in MED in Q2 2013 and held it in 1 quarter. The position peaked at $4K in Q2 2013. 140 funds tracked by Wall St. Rank hold MED as of Q3 2013.

Smithfield Trust reported no remaining Medifast position as of Q3 2013 after selling out during the quarter.
Smithfield Trust sold 160 Medifast shares in Q3 2013, an estimated $4K.
Smithfield Trust first reported a position in Medifast in Q2 2013 and held it in 1 quarter.
Smithfield Trust's Medifast position peaked at $4K in Q2 2013.
140 funds tracked by Wall St. Rank held Medifast as of Q3 2013.

Based on Smithfield Trust's 13F filing for Q3 2013, filed 17 Oct 2013.